Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 26

1.

Immature-like molecular expression patterns in the hippocampus of a mouse model of dementia with Lewy body-linked mutant β-synuclein.

Hagihara H, Fujita M, Umemori J, Hashimoto M, Miyakawa T.

Mol Brain. 2018 Jul 6;11(1):38. doi: 10.1186/s13041-018-0378-3.

2.

Ulk4 regulates GABAergic signaling and anxiety-related behavior.

Liu M, Fitzgibbon M, Wang Y, Reilly J, Qian X, O'Brien T, Clapcote S, Shen S, Roche M.

Transl Psychiatry. 2018 Feb 2;8(1):43. doi: 10.1038/s41398-017-0091-5.

3.

Genetic variation of GRIA3 gene is associated with vulnerability to methamphetamine dependence and its associated psychosis.

Iamjan SA, Thanoi S, Watiktinkorn P, Reynolds GP, Nudmamud-Thanoi S.

J Psychopharmacol. 2018 Mar;32(3):309-315. doi: 10.1177/0269881117750153. Epub 2018 Jan 17.

PMID:
29338492
4.

Functional analysis of schizophrenia genes using GeneAnalytics program and integrated databases.

Sundararajan T, Manzardo AM, Butler MG.

Gene. 2018 Jan 30;641:25-34. doi: 10.1016/j.gene.2017.10.035. Epub 2017 Oct 13.

PMID:
29032150
5.

GluA1 AMPAR subunit deletion reduces the hedonic response to sucrose but leaves satiety and conditioned responses intact.

Austen JM, Sprengel R, Sanderson DJ.

Sci Rep. 2017 Aug 7;7(1):7424. doi: 10.1038/s41598-017-07542-9.

6.

Altered balance of excitatory and inhibitory learning in a genetically modified mouse model of glutamatergic dysfunction relevant to schizophrenia.

Sanderson DJ, Lee A, Sprengel R, Seeburg PH, Harrison PJ, Bannerman DM.

Sci Rep. 2017 May 11;7(1):1765. doi: 10.1038/s41598-017-01925-8.

7.

Pharmacogenetic Analysis of Functional Glutamate System Gene Variants and Clinical Response to Clozapine.

Taylor DL, Tiwari AK, Lieberman JA, Potkin SG, Meltzer HY, Knight J, Remington G, Müller DJ, Kennedy JL.

Mol Neuropsychiatry. 2017 Feb;2(4):185-197. doi: 10.1159/000449224. Epub 2016 Oct 12.

8.

The group II metabotropic glutamate receptor agonist LY354740 and the D2 receptor antagonist haloperidol reduce locomotor hyperactivity but fail to rescue spatial working memory in GluA1 knockout mice.

Boerner T, Bygrave AM, Chen J, Fernando A, Jackson S, Barkus C, Sprengel R, Seeburg PH, Harrison PJ, Gilmour G, Bannerman DM, Sanderson DJ.

Eur J Neurosci. 2017 Apr;45(7):912-921. doi: 10.1111/ejn.13539. Epub 2017 Mar 4.

9.

No association of GRIA1 polymorphisms with schizophrenia in the Chinese Han population.

Niu W, Huang X, Yu T, Chen S, Li X, Wu X, Cao Y, Zhang R, Bi Y, Yang F, Wang L, Li W, Xu Y, He L, He G.

Psychiatr Genet. 2016 Apr;26(2):97-8. doi: 10.1097/YPG.0000000000000117. No abstract available.

PMID:
26862833
10.

Characterization of a Novel Mutation in SLC1A1 Associated with Schizophrenia.

Afshari P, Myles-Worsley M, Cohen OS, Tiobech J, Faraone SV, Byerley W, Middleton FA.

Mol Neuropsychiatry. 2015 Oct;1(3):125-44. doi: 10.1159/000433599. Epub 2015 Jul 8.

11.

Low expression of Gria1 and Grin1 glutamate receptors in the nucleus accumbens of Spontaneously Hypertensive Rats (SHR).

Diana MC, Santoro ML, Xavier G, Santos CM, Spindola LN, Moretti PN, Ota VK, Bressan RA, Abilio VC, Belangero SI.

Psychiatry Res. 2015 Oct 30;229(3):690-4. doi: 10.1016/j.psychres.2015.08.021. Epub 2015 Aug 12.

PMID:
26296755
12.

Addiction and reward-related genes show altered expression in the postpartum nucleus accumbens.

Zhao C, Eisinger BE, Driessen TM, Gammie SC.

Front Behav Neurosci. 2014 Nov 5;8:388. doi: 10.3389/fnbeh.2014.00388. eCollection 2014.

13.

What causes aberrant salience in schizophrenia? A role for impaired short-term habituation and the GRIA1 (GluA1) AMPA receptor subunit.

Barkus C, Sanderson DJ, Rawlins JN, Walton ME, Harrison PJ, Bannerman DM.

Mol Psychiatry. 2014 Oct;19(10):1060-70. doi: 10.1038/mp.2014.91. Epub 2014 Sep 16. Review.

14.

Chronic treatment with mood-stabilizers attenuates abnormal hyperlocomotion of GluA1-subunit deficient mice.

Maksimovic M, Vekovischeva OY, Aitta-aho T, Korpi ER.

PLoS One. 2014 Jun 16;9(6):e100188. doi: 10.1371/journal.pone.0100188. eCollection 2014.

15.

Design and interpretation of microRNA-reporter gene activity.

Carroll AP, Tooney PA, Cairns MJ.

Anal Biochem. 2013 Jun 15;437(2):164-71. doi: 10.1016/j.ab.2013.02.022. Epub 2013 Mar 7.

PMID:
23481915
16.

Epigenetic changes at gene promoters in response to immune activation in utero.

Tang B, Jia H, Kast RJ, Thomas EA.

Brain Behav Immun. 2013 May;30:168-75. doi: 10.1016/j.bbi.2013.01.086. Epub 2013 Feb 9.

PMID:
23402795
17.

Genetic variants of GRIA1 are associated with susceptibility to schizophrenia in Korean population.

Kang WS, Park JK, Kim SK, Park HJ, Lee SM, Song JY, Chung JH, Kim JW.

Mol Biol Rep. 2012 Dec;39(12):10697-703. doi: 10.1007/s11033-012-1960-x. Epub 2012 Oct 8.

PMID:
23053966
18.

Convergent functional genomics of schizophrenia: from comprehensive understanding to genetic risk prediction.

Ayalew M, Le-Niculescu H, Levey DF, Jain N, Changala B, Patel SD, Winiger E, Breier A, Shekhar A, Amdur R, Koller D, Nurnberger JI, Corvin A, Geyer M, Tsuang MT, Salomon D, Schork NJ, Fanous AH, O'Donovan MC, Niculescu AB.

Mol Psychiatry. 2012 Sep;17(9):887-905. doi: 10.1038/mp.2012.37. Epub 2012 May 15.

19.

Influence of GRIA1, GRIA2 and GRIA4 polymorphisms on diagnosis and response to antipsychotic treatment in patients with schizophrenia.

Crisafulli C, Chiesa A, De Ronchi D, Han C, Lee SJ, Park MH, Patkar AA, Pae CU, Serretti A.

Neurosci Lett. 2012 Jan 6;506(1):170-4. doi: 10.1016/j.neulet.2011.10.074. Epub 2011 Nov 6.

PMID:
22094384
20.

Association study of the GRIA1 and CLINT1 (Epsin 4) genes in a German schizophrenia sample.

Leon CA, Schumacher J, Kluck N, Herold C, Schulze TG, Propping P, Rietschel M, Cichon S, Nöthen MM, Jamra RA.

Psychiatr Genet. 2011 Apr;21(2):114. doi: 10.1097/YPG.0b013e328341a334. No abstract available.

PMID:
21116212

Supplemental Content

Loading ...
Support Center